1 |
Schijns, V. E. and Tangeras, A. 2005. Vaccine adjuvant technology: from theoretical mechanisms to practical approaches. Dev. Biol. (Basel) 121, 127-134.
|
2 |
Tobacman, J. K. 2001. Review of harmful gastrointestinal effects of carrageenan in animal experiments. Environ. Health Perspect. 109, 983-994.
DOI
|
3 |
Zia, K. M., Tabasum, S., Nasif, M., Sultan, N., Aslam, N., Noreen, A. and Zuber, M. 2017. A review on synthesis, properties and applications of natural polymer based carrageenan blends and composites. Int. J. Biol. Macromol. 96, 282-301.
DOI
|
4 |
Campo, V. L., Kawano, D. F., Silva, D. B. and Carvalho, D. I. 2009. Carrageenans: Biological properties, chemical modifications and structural analysis- A review. Carbohydr. Polym. 77, 167-180.
DOI
|
5 |
Anver, M. R. and Cohen, J. 1976. Animal model of human disease. Ulcerative colitis, Animal model: ulcerative colitis induced in guinea pigs with degraded carrageenan. Am. J. Pathol. 84, 431-434.
|
6 |
Ariffin, S. H., Yeen, W. W., Abidin, I. Z., Abdul Wahab, R. M., Ariffin, Z. Z. and Senafi, S. 2014. Cytotoxicity effect of degraded and undegraded Kappa and iota carrageenan in human intestine and liver cell lines. BMC Complement Altern. Med. 14, 508-523.
DOI
|
7 |
Ashi, K. W., Inagaki, T., Fujimoto, Y. and Fukuda, Y. 1978. Induction by degraded carrageenan of colorectal tumors in rats. Cancer Lett. 4, 171-176.
DOI
|
8 |
Barth, C. R., Funchal, G. A., Luft, C., de Oliveira, J. R., Porto, B. N. and Donadio, M. V. 2016. Carrageenan-induced inflammation promotes ROS generation and neutrophil extracellular trap formation in a mouse model of peritonitis. Eur. J. Immunol. 46, 964-970.
DOI
|
9 |
Brunner, R., Jensen-Jarolim, E. and Pali-Scholl, I. 2010. The ABC of clinical and experimental adjuvants-a brief overview. Immunol. Lett. 128, 29-35.
DOI
|
10 |
Chen, H., Wang, F., Mao, H. and Yan, X. 2014. Degraded -carrageenan activates NF-kB and AP-1 pathways in macrophages and enhances LPS-induced TNF- secretion through AP-1. Biochim. Biophys. Acta. 1840, 2162-2170.
DOI
|
11 |
Jiao, G., Yu, G., Zhang, J. and Ewart, H. S. 2011. Chemical structures and bioactivities of sulfated polysaccharides from marine algae. Mar. Drugs 9, 196-223.
DOI
|
12 |
Ekstrom, L. G. 1985. Molecular weight distribution and the behavior of kappa-carrageenan on hydrolysis. Carbohydr. Res. 135. 283-289.
DOI
|
13 |
Ekstrom, L. G., Kuivinen, J. and Johansson, G. 1983. Molecular weight distribution and hydrolysis behavior of carrageenans. Carbohydr. Res. 116, 89-94..
DOI
|
14 |
Fath, R. B Jr., Deschner, E. E., Winawer, S. J. and Dworkin, B. M. 1984. Degraded carrageenan-induced colitis in CF1 mice. Digestion 29, 197-203.
DOI
|
15 |
Fischetti, L., Zhong, Z., Pinder, C. L., Tregoning, J. S. and Shattock, R. J. 2017. The synergistic effects of combining TLR ligand based adjuvants on the cytokine response are dependent upon p38/JNK signaling. Cytokine 99, 287-296.
DOI
|
16 |
HogenEsch, H. 2002. Mechanisms of stimulation of the im mune response by aluminum adjuvants. Vaccine 20 Suppl 3, S34-39.
DOI
|
17 |
Masson, C. R. and Caines, G. W. 1954. Viscosity and molecular weight of degraded carrageenan. Can. J. Chem. 32, 51-59.
DOI
|
18 |
Morris, C. J. 2003. Carrageenan-induced paw edema in the rat and mouse. Methods Mol. Biol. 225, 115-121.
|
19 |
Oohashi, Y., Ishioka, T., Wakabayashi, K. and Kuwabara, N. 1981. A study on carcinogenesis induced by degraded carrageenan arising from squamous metaplasia of the rat colorectum. Cancer Lett. 14, 267-272.
DOI
|
20 |
Duarte, D. B., Vasko, M. R. and Fehrenbacher, J. C. 2016. Models of inflammation: Carrageenan Air Pouch. Curr. Protoc. Pharmacol. 72, 561-569.
|
21 |
Prajapati, V. D., Maheriya, P. M., Jani, G. K. and Solanki, H. K. 2014. Carrageenan: a natural seaweed polysaccharide and its applications. Carbohydr. Polym. 105, 97-112.
DOI
|